News

  1. 07/12/2018 Catalent Appoints Marlene Leuenberger as General Manager

  2. 07/10/2018 Catalent Biologics Adopts Berkeley Lights’ Beacon® Optofluidic Platform

  3. 07/03/2018 Catalent Signs Agreement to Acquire Juniper Pharmaceuticals, Inc.

  4. 06/26/2018 Catalent Biologics Appoints New General Manager for Madison, Wisconsin

  5. 06/13/2018 Catalent Appoints Paul Hegwood as New President of Clinical Supply Services

  6. 06/07/2018 Biological Drug Development & Delivery at Catalent Institute / JLABS Symposium

  7. 05/31/2018 Catalent Biologics Supports New Methamphetamine Treatment

  8. 05/17/2018 Catalent Completes $5.5 Million Expansion at Kansas City

  9. 05/14/2018 Catalent Biologics and Valerius Biopharma to Collaborate on Biosimilars

  10. 04/24/2018 Catalent Invest $5 million to Create Drug Development Center of Excellence

  11. 04/19/2018 Catalent to Lead Multiple Workshops at Upcoming US GCSG Conference

  12. 04/12/2018 Catalent Completes $5.5 Million Expansion at Philadelphia Facility

  13. 04/11/2018 Catalent to Present at Upcoming INTERPHEX Convention

  14. 03/08/2018 Catalent To Discuss Potential Implications of Brexit on Clinical Supply

  15. 03/01/2018 Catalent Institute to Host Discussion on Patient-Focused Drug Design

  16. 02/28/2018 Catalent Completes $4.6 Million Expansion at Singapore Facility

  17. 02/22/2018 Catalent to Present at Clinical Trial Supply New England

  18. 02/21/2018 Biohaven Announces Exclusive License with Catalent for Zydis® ODT

  19. 02/05/2018 Catalent Recognized with 10 CMO Leadership Awards

  20. 01/29/2018 Catalent Biologics to Present at CASSS WCBP Symposium